Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int Immunopharmacol. 2010 Dec;10(12):1496-500. doi: 10.1016/j.intimp.2010.06.019. Epub 2010 Jul 7.

The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.

Author information

  • 1Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands. m.hoogduijn@erasmusmc.nl

Abstract

There is growing interest in the use of mesenchymal stem cells (MSC) for immune therapy. Clinical trials that use MSC for treatment of therapy resistant graft versus host disease, Crohn's disease and organ transplantation have initiated. Nevertheless, the immunomodulatory effects of MSC are only partly understood. Clinical trials that are supported by basic research will lead to better understanding of the potential of MSC for immunomodulatory applications and to optimization of such therapies. In this manuscript we review some recent literature on the mechanisms of immunomodulation by MSC in vitro and animal models, present new data on the secretion of pro-inflammatory and anti-inflammatory cytokines, chemokines and prostaglandins by MSC under resting and inflammatory conditions and discuss the hopes and expectations of MSC-based immune therapy.

Copyright © 2010 Elsevier B.V. All rights reserved.

PMID:
20619384
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk